418 related articles for article (PubMed ID: 10805251)
1. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
Johnstone IB; Martin CA
Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
[TBL] [Abstract][Full Text] [Related]
2. Practical application of the protein C activator Protac from Agkistrodon contortrix venom.
Stocker K; Fischer H; Meier J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):260-4. PubMed ID: 2465212
[TBL] [Abstract][Full Text] [Related]
3. Coagulation studies f plasmas from healthy domesticated animals and persons.
Greene CE; Tsang VC; Prestwood AK; Meriwether EA
Am J Vet Res; 1981 Dec; 42(12):2170-7. PubMed ID: 7340587
[TBL] [Abstract][Full Text] [Related]
4. Protein C activators in snake venoms.
Stocker K; Fischer H; Meier J; Brogli M; Svendsen L
Behring Inst Mitt; 1986 Feb; (79):37-47. PubMed ID: 3755037
[TBL] [Abstract][Full Text] [Related]
5. Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects.
Okajima K; Koga S; Kaji M; Inoue M; Nakagaki T; Funatsu A; Okabe H; Takatsuki K; Aoki N
Thromb Haemost; 1990 Feb; 63(1):48-53. PubMed ID: 2140205
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
7. [Antithrombotic effect of protein C activator from a snake venom].
Strukova SM; Kogan AE; Tara AA; Aaviksaar AA
Vopr Med Khim; 1989; 35(5):115-9. PubMed ID: 2617927
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of coagulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S.
D'Angelo SV; Gilardoni F; D'Angelo A
Thromb Haemost; 1989 Nov; 62(3):861-7. PubMed ID: 2531939
[TBL] [Abstract][Full Text] [Related]
9. [Research on the protein C-activating property and influencial factors of protein C activator isolated from the venom of Agkistrodon halys].
Hou L; Zhao L; Zhao Z; Huang S; He Q; Kong T; Guan J
Zhong Yao Cai; 2005 Mar; 28(3):198-201. PubMed ID: 16107029
[TBL] [Abstract][Full Text] [Related]
10. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
[TBL] [Abstract][Full Text] [Related]
11. Functional assays for protein C activity and protein C inhibitor activity in plasma.
Geiger M; White TM; Griffin JH
Thromb Haemost; 1989 Feb; 61(1):86-92. PubMed ID: 2546280
[TBL] [Abstract][Full Text] [Related]
12. [The effect of factor VIII:C activity on the activated partial thromboplastin time (aPTT) in the dog. Adaptation of the aPTT as a screening test for canine hemophilia A?].
Mischke R
Dtsch Tierarztl Wochenschr; 1993 Jun; 100(6):219-22. PubMed ID: 8339706
[TBL] [Abstract][Full Text] [Related]
13. Mitigation of coagulation by removing clotting factors part 1: in vitro feasibility study.
Parker JT; Beutler DS; Sukavaneshvar S; Jacobs N; Solen KA; Mohammad SF
ASAIO J; 2007; 53(4):415-20. PubMed ID: 17667224
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
Mischke R
Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
[TBL] [Abstract][Full Text] [Related]
15. The monitoring of heparin administration by screening tests in experimental dogs.
Mischke R; Jacobs C
Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
[TBL] [Abstract][Full Text] [Related]
16. Prekallikrein deficiency in a family of miniature horses.
Turrentine MA; Sculley PW; Green EM; Johnson GS
Am J Vet Res; 1986 Nov; 47(11):2464-7. PubMed ID: 3641551
[TBL] [Abstract][Full Text] [Related]
17. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
Mischke R
Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
[TBL] [Abstract][Full Text] [Related]
18. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
Francis JL; Howard C
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):35-40. PubMed ID: 7681330
[TBL] [Abstract][Full Text] [Related]
19. A simple functional protein S assay using PROTAC.
Han P; Pradham M
Clin Lab Haematol; 1990; 12(2):201-8. PubMed ID: 2145113
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of detergent sclerosants on antithrombotic mechanisms.
Parsi K; Exner T; Low J; Ma DD; Joseph JE
Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):220-8. PubMed ID: 19442540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
